Crossmark

The association between county-level premature cardiovascular mortality related to cardio-kidney-metabolic disease and the social determinants of health in the US.

Crossref DOI link: https://doi.org/10.1038/s41598-024-73974-9

Published Online: 2024-10-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cotton, Antoinette

Salerno, Pedro R V O

Deo, Salil V

Virani, Salim

Nasir, Khurram

Neeland, Ian

Rajagopalan, Sanjay

Sattar, Naveed

Al-Kindi, Sadeer

Elgudin, Yakov E
Funding

Funding for this research was provided by:

Johnson and Johnson

Afimmune, Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Hanmi Pharmaceuticals, Merck Sharp & Dohme, Novartis, Novo Nordisk, Pfizer, and Sanofi

AstraZeneca, Boehringer Ingelheim, Novartis, and Roche Diagnostics

National Institute of Minority Health
License Information

Text and Data Mining valid from 2024-10-23

Version of Record valid from 2024-10-23
More Information

Article History

Received: 13 March 2024

Accepted: 23 September 2024

First Online: 23 October 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below